Sugar.fit, a healthtech startup in India concentrating on diabetes management, has secured an additional US$5 million in its series A funding round, led by B Capital. This extension brings the total funding of the series A round to US$16 million.
- Investors: Notable investors in this round include B Capital, established by Facebook co-founder Eduardo Saverin, along with previous backers such as MassMutual Ventures, Tanglin Venture Partners, and Endiya Partners.
- Company Background: Founded in 2021, Sugar.fit offers a subscription-based program for diabetes reversal, combining technology with personalized interventions.
- Market Context: India faces significant diabetes challenges, with approximately 77 million adults living with Type 2 diabetes, according to the World Health Organization. Karan Mohla, general partner at B Capital, highlighted India’s dual disease burden and the persistent challenges of access, affordability, and quality in healthcare.
- Future Plans: Sugar.fit intends to utilize the newly secured funds to enhance brand presence and strengthen research and development efforts.
This funding extension underscores Sugar.fit’s commitment to addressing the growing diabetes epidemic in India through innovative technological solutions and personalized care approaches.
